Page 1 of Clinical Trials for Intercell AG [SPONSOR-COLLABORATORS], 24 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
Last Updated: June 29, 2011
Condition(s): Japanese Encephalitis
2
Completed
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
Last Updated: January 16, 2008
Condition(s): Japanese Encephalitis
3
Completed
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Last Updated: June 2, 2010
Condition(s): Japanese Encephalitis
4
Recruiting
Safety Surveillance After Immunization With IXIARO
Last Updated: April 13, 2011
Condition(s): Japanese Encephalitis
5
Completed
Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling
Last Updated: November 24, 2010
Condition(s): Japanese Encephalitis
6
Completed
Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47
Last Updated: April 26, 2010
Condition(s): Pneumococcal Infections
7
Not yet recruiting
Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination
Last Updated: April 4, 2012
Condition(s): Japanese Encephalitis
8
Recruiting
Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries
Last Updated: January 12, 2012
Condition(s): Encephalitis
9
Completed
Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients
Last Updated: June 2, 2010
Condition(s): Ventilated Associated Pneumonia
10
Completed
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51
Last Updated: January 15, 2008
Condition(s): Japanese Encephalitis
11
Active, not recruiting
Open-label, Randomized Study in a Pediatric Population in a JEV(Japanese Encephalitis Vaccine)-Endemic Country
Last Updated: November 7, 2011
Condition(s): Japanese Encephalitis
12
Recruiting
Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43
Last Updated: March 22, 2012
Condition(s): Pseudomonas Aeruginosa Infection
13
Completed
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51
Last Updated: June 20, 2008
Condition(s): Japanese Encephalitis
14
Completed
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Last Updated: November 7, 2011
Condition(s): Japanese Encephalitis
15
Completed
Virological Response Study of the HCV Vaccine IC41
Last Updated: March 21, 2012
Condition(s): Chronic Hepatitis C
16
Completed
Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440
Last Updated: January 15, 2008
Condition(s): Japanese Encephalitis
17
Completed
Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population
Last Updated: November 7, 2011
Condition(s): Encephalitis
18
Recruiting
Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study
Last Updated: March 22, 2012
Condition(s): Japanese Encephalitis
19
Completed
Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine
Last Updated: January 15, 2008
Condition(s): Chronic Hepatitis C
20
Completed
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
Last Updated: January 16, 2008
Condition(s): Japanese Encephalitis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Intercell+AG

Page 1 of Clinical Trials for Intercell AG [SPONSOR-COLLABORATORS], 24 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About